A German pharmacy offering the venöse Blutentnahme (venous blood draw) will at some point hand over a result outside the Referenzbereich (reference range). The question every Apothekenleiter asks first is what happens then and who carries it.
The answer is short. The pharmacy does not interpret the result, it routes it. Diagnosis, Indikationsstellung (the decision that a test is medically needed) and therapy stay with the doctor.
What makes that work under pressure is a written Eskalationspfad (escalation path): three result categories, one named owner per step, fixed wording and a log. Held in the Standardarbeitsanweisung, it closes the gap the medical associations name in public.
The pharmacy reports the value and the doctor interprets it
This boundary predates the reform. The Apothekenversorgung-Weiterentwicklungsgesetz (ApoVWG), covered in our ApoVWG guide, made the venöse Blutentnahme lawful through § 11c ApoG from 2 July 2026 and left interpretation where it was.
§ 1a Abs. 11 ApBetrO permits physiologisch-chemische Untersuchungen only „in dem Umfang …, in dem sich die Tätigkeiten auf die Ermittlung und Bekanntgabe der Messwerte beschränken“, so the work stops at determining and communicating the values. The Leitlinie der Bundesapothekerkammer of 14 May 2024 requires the counselling to carry the „Hinweis, dass Diagnose und Therapie Aufgaben des Arztes sind“.
Three result categories decide what happens next
A workable Eskalationspfad sorts every laboratory report into one of three categories before anyone speaks to the customer. The report does the sorting, because the laboratory marks values against the Referenzbereich and flags a kritischer Wert, a value calling for medical contact the same day.
| Result category | What the pharmacy says | What it documents | What happens next |
|---|
| Values inside the Referenzbereich |
Values sit inside the Referenzbereich, and diagnosis and therapy remain the doctor's task |
Date, the wording used, the pharmacist who released the Befund |
The Befund goes to the customer and the case closes |
| Values outside the Referenzbereich without urgency |
Values sit outside the Referenzbereich, the pharmacy does not interpret them, and a medical appointment is advisable |
Which values fell outside, the wording used, the recommendation, the date, the person |
The customer takes the Befund to a doctor of their own choosing |
| Values the laboratory flags as a kritischer Wert |
The laboratory has flagged the result for same day medical contact, read out as the laboratory worded it |
Arrival time, time and channel of each contact attempt, the wording used, the outcome |
Same day contact with a doctor or the ärztlicher Bereitschaftsdienst, with a recorded follow up |
Every step in the path has one named owner
The delegation rules under § 11c ApoG are narrow. Only an approbierter Apotheker may perform the blood draw, after a confirmed ärztliche Schulung (medical training), in their own öffentliche Apotheke, on people aged 18 or over, purely for diagnostic purposes.
The puncture alone may be delegated to a PhiP (Pharmazeut im Praktikum) under supervision, and only after that PhiP has their own ärztliche Schulung. Aufklärung (informed explanation), Anamnese and consent never delegate. A PTA may not perform the blood draw and may only support preparation and documentation under ApBetrO § 35b Abs. 2, a point the trade press confuses with vaccination rules, as our post on what a PTA may do explains.
Because Aufklärung never delegates, the person who explains the path beforehand answers for it afterwards. Most pharmacies name the Apothekenleiter or one deputy pharmacist as the only people permitted to make the same day contact.
The Standardarbeitsanweisung makes the path auditable
Operational duties under § 11c ApoG include a room not used for anything else during the blood draw, assured privacy, Standardarbeitsanweisungen held in the Qualitätsmanagementsystem under ApBetrO § 35b Abs. 1, and notification of the state authority at least one week before starting and again before any change to the procedure or the rooms. A revision of the Eskalationspfad counts as such a change.
The Muster-SOP of the Bundesapothekerkammer supplies the frame: Gegenstand, Geltungsbereich, Zuständigkeiten, Verfahren, Dokumentation and mitgeltende Unterlagen, with a version number, an author and an approver. The Eskalationspfad sits under Verfahren and names:
- who receives the laboratory report, through which channel and how fast
- the three result categories, the trigger for each and the exact wording used
- who makes the same day contact, where the record is stored and how long it is kept
One date is often misread: the 1 September 2026 SOP deadline binds the Bundesapothekerkammer rather than individual pharmacies.
Documentation is the liability defence and not the liability risk
Owners often assume a log creates evidence against them, and the reverse is true. The pharmacy's position rests on having stayed inside the Ermittlung und Bekanntgabe der Messwerte, and only a record of what was said, by whom and when shows that. Without one the pharmacy argues from memory on Haftung (liability).
The Kommentar zur Leitlinie sets a retention rule nearby: „Die gesamte Dokumentation für die interne und externe Qualitätskontrolle ist fünf Jahre aufzubewahren“. The period for an escalation log is not separately fixed [team to confirm with the responsible chamber].
Risk comes from the contents, not from the log. Timestamps, wording, the person acting and the outcome belong in it. Written speculation about what a value might mean does not.
Some customers refuse to see a doctor
This is the scenario nobody writes about and every pharmacy meets. An adult can decline medical care and a pharmacy cannot compel anyone.
The path still holds a defined response. The recommendation is repeated once in plain wording, the refusal is recorded in neutral terms alongside it, and a written copy of the Befund is offered for later use. Where the customer agrees, a follow up call is arranged.
Two limits deserve stating. The pharmacy does not contact a doctor over the customer's head, because the Befund is health data the customer controls. And the recommendation points to a doctor rather than a named practice, because the Zuweisungsverbot bars steering patients to a particular provider. The cheapest place to settle this is the Aufklärung before the blood draw.
The SpiFa and KBV criticism names a real gap
On 22 May 2026 the Spitzenverband Fachärzte Deutschlands (SpiFa) said through Dr. Dirk Heinrich that „Blutabnahme ist nicht bloß ein technischer Handgriff“ and that „Diagnostik endet nicht an der Kanüle“, meaning diagnosis does not stop at the puncture. Its statement names the open points as „Verantwortlichkeiten bei auffälligen Befunden sowie die medizinische Einordnung“.
Two days earlier the board of the Kassenärztliche Bundesvereinigung wrote that the plan „lese sich ein wenig wie ein Programm für ‚Jugend forscht‘“, and that ärztliche Diagnostik, Indikationsstellung und Therapie are not building blocks to be handed to others at will. Its PraxisNachrichten of 18 June 2026 told practices to expect people arriving „um einen unklaren Befund ärztlich bewerten oder abklären zu lassen“.
Both are right that § 11c ApoG does not spell out an escalation path. A documented Eskalationspfad answers part of that, because it names the owner of each step and produces a record a chamber or a court can read.
It does not create an Indikationsstellung, so a test taken without a medical question still reaches a practice as a question. What changes is what walks through the practice door: a legible Befund from an accredited laboratory with a recorded reason instead of an unexplained printout, which our post on the criticism of the reform takes further.
An accredited laboratory flags the values that need same day contact
An akkreditiertes Labor (accredited laboratory) working to DIN EN ISO 15189 runs a postanalytical process for this. German laboratories keep an internal extreme value list. Labor Dr. Wisplinghoff describes the practice: „Kritische Laborergebnisse werden gemäß einer hinterlegten Extremwertliste … dem behandelnden Arzt sofort telefonisch oder per Fax mitgeteilt“.
So the sorting is done when the report reaches the pharmacy, and the flag does not depend on anyone at the counter recognising a pattern. That is a real advantage over an unsupported Point-of-Care-Test, where the device shows a number and the person beside it decides what it means. The Leitlinie leaves the device workflow at a „Prüfung des Ergebnisses auf Plausibilität, Vergleich mit Referenzwert“, the same work with less support behind it. We compare both routes in our post on point of care testing.
Questions pharmacy owners ask about abnormal blood results
Does a pharmacy have to interpret a blood result it hands over?
No. § 1a Abs. 11 ApBetrO limits physiologisch-chemische Untersuchungen to determining and communicating the values, and the Leitlinie asks the pharmacy to state that diagnosis and therapy are the doctor's task.
May a PTA make the contact when a result comes back outside the Referenzbereich?
A PTA may not perform the venöse Blutentnahme and may only support preparation and documentation under ApBetrO § 35b Abs. 2. The Standardarbeitsanweisung names which pharmacist makes the escalation contact and who deputises.
What happens when the customer refuses to see a doctor?
A pharmacy cannot compel an adult to seek medical care. The recommendation is repeated once, the refusal is recorded in neutral terms, and a written copy of the Befund is offered. The pharmacy does not contact a doctor over the customer's head, because the Befund is health data.
Does documenting the escalation increase liability exposure?
The record is the evidence that the pharmacy stayed inside its remit, so it works as a defence rather than as an exposure. What raises risk is written speculation about what a value means.
What a pharmacy does next
The Eskalationspfad is drafted as a section of the Standardarbeitsanweisung with the three categories, the fixed wording and the named owners. The laboratory partner is asked in writing how and how fast it flags a kritischer Wert, because that sets the pharmacy's own timings. The path is then walked through once with the whole team, including the refusal case, before the notification goes to the authority.
The log runs from the first customer onward, and the path is reviewed whenever the laboratory, the rooms or staffing change. Related reading sits in our post on self tests compared with laboratory tests and in the glossary entry on Qualitätssicherung.
This article is general information about German pharmacy law and business practice. It is not legal advice. The responsible Apothekerkammer or a lawyer decides individual cases.
